Table 1 Clinical characteristics of 90 children enrolled in this study
CharacCstics | All patients (%) | Severe respiratory infections group (%) | Non severe respiratory infection group (%) |
|---|---|---|---|
No. | 90 | 48 | 42 |
Gender | |||
Male | 52 (57.80) | 28 (58.3) | 25 (59.52) |
Female | 38 (42.20) | 20 (41.7) | 17 (40.48) |
Age | |||
<1 year | 31 (34.44) | 15 (31.25) | 16 (38.10) |
1-2 years | 29 (32.22) | 18 (37.50) | 11 (26.19) |
3-5 years | 22 (24.44) | 13 (27.08) | 9 (21.43) |
6-14 years | 8 (8.89) | 2 (4.17) | 6 (14.29) |
Hospitalization stay (days) | 18.36±19.31 | 19.40±20.38 | 17.17±18.19 |
Cost (RMB) | 61222.26±87707.67 | 73978.42±101649.49 | 46643.81±66676.26 |
Use of anti-virus (%) | 20 (22.22) | 17 (35.42) | 3 (7.14) |
Days of antibiotic use (d) | 8.68±5.59 | 8.76±6.25 | 8.58±4.67 |
Use of glucocorticoid (%) | 60 (66.67) | 40 (83.33) | 20 (47.62) |
Underlying diseases | |||
None | 62(68.89) | 34 (70.83) | 28 (66.67) |
Heart diseases | 9 (10.00) | 4 (8.33) | 5 (11.90) |
Intestinal diseases | 6 (6.67) | 4 (8.33) | 2 (4.76) |
Central Nervous diseases | 5 (5.56) | 1 (2.08) | 4 (9.52) |
Other diseases | 8 (8.89) | 5 (10.42) | 3 (7.14) |
Clinical outcome | |||
Improved | 74 (82.22) | 37 (77.08) | 37 (88.10) |
Unhealed | 13 (14.45) | 9 (18.75) | 4 (9.52) |
Died | 3 (3.33) | 2 (4.17) | 1 (2.38) |